Odu Digital Commonsmetadata only
Circulating Biomarker Results from a Phase 2 Study of Seralutinib in Pulmonary Arterial Hypertension
hemodynamics, inflammation mediators, molecular mechanisms of pharmacological action, tyrosine kinase inhibitor, vascular remodeling, cellular and molecular physiology, hematology, hemic and immune systems
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Record · ID 224930
Conceptio Open Knowledge Archive — every document is proof-bundled with source, license, and retrieval metadata.